- Home
- CERS vs MQT Comparison
CERS vs MQT Comparison
Compare CERS & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- MQT
- Stock Information
- Founded
- CERS 1991
- MQT 1992
- Country
- CERS United States
- MQT United States
- Employees
- CERS N/A
- MQT N/A
- Industry
- CERS EDP Services
- MQT Investment Bankers/Brokers/Service
- Sector
- CERS Technology
- MQT Finance
- Exchange
- CERS Nasdaq
- MQT Nasdaq
- Market Cap
- CERS 255.0M
- MQT 212.5M
- IPO Year
- CERS 1997
- MQT N/A
- Fundamental
- Price
- CERS $1.30
- MQT $9.85
- Analyst Decision
- CERS Strong Buy
- MQT
- Analyst Count
- CERS 2
- MQT 0
- Target Price
- CERS $3.50
- MQT N/A
- AVG Volume (30 Days)
- CERS 1.2M
- MQT 52.5K
- Earning Date
- CERS 10-29-2025
- MQT 01-01-0001
- Dividend Yield
- CERS N/A
- MQT 4.60%
- EPS Growth
- CERS N/A
- MQT N/A
- EPS
- CERS N/A
- MQT N/A
- Revenue
- CERS $192,510,000.00
- MQT N/A
- Revenue This Year
- CERS $30.03
- MQT N/A
- Revenue Next Year
- CERS $9.37
- MQT N/A
- P/E Ratio
- CERS N/A
- MQT N/A
- Revenue Growth
- CERS 13.25
- MQT N/A
- 52 Week Low
- CERS $1.12
- MQT $8.59
- 52 Week High
- CERS $2.24
- MQT $10.67
- Technical
- Relative Strength Index (RSI)
- CERS 50.21
- MQT 71.74
- Support Level
- CERS $1.26
- MQT $9.47
- Resistance Level
- CERS $1.35
- MQT $9.56
- Average True Range (ATR)
- CERS 0.07
- MQT 0.08
- MACD
- CERS 0.01
- MQT 0.03
- Stochastic Oscillator
- CERS 51.72
- MQT 95.83
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.